A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma. - Hainsworth, John D.; Infante, Jeffrey R.; Spigel, David R.; Arrowsmith, Edward R.; Boccia, Ralph V.; Burris, Howard A. (Cancer Investigation, 2011)